The Significance of STI Testing: Mycoplasma genitalium and Opt-Out Screening for Chlamydia and Gonorrhea

Watch Drs. Tonya Chaffee and Irene Stafford discuss the increasing rate of Sexually Transmitted Infections (STI) in the U.S. population. The following topics will be addressed: the importance of opt-out screening as the most effective strategy to reduce STI prevalence in chlamydia and gonorrhea and real-world data reflective of current clinical practices in the U.S. for Mycoplasma genitalium and ways to improve patient care through established testing guidelines.

LEARN ABOUT DR. CHAFFEE AND DR. STAFFORD.